~~<i id='3F4902E850'><strike id='3F4902E850'><tt id='3F4902E850'><pre id='3F4902E850'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

explore

hotspot

author：entertainment 2025-09-29 22:47:01 - browse：4

Pharmacists increasingly are being asked to make drugs in bulk for hospitals that are in short supply, and they’re even beginning to make chemotherapies. But some in the industry worry about the unintended consequences of overreliance.

Hospitals’ reliance on pharmacist-made drugs, a practice called compounding, has risen in step with worsening drug shortages.

When the American Society of Health-System Pharmacists surveyed its members this past summer, 59% said they increased purchases from compounders because of drug shortages.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： BioMarin wins approval for gene therapy to treat hemophilia A
Next article： Winning ticket for $1 billion Powerball jackpot sold in California

leisure time

focus

hotspot

knowledge

explore

1:30PoliceofficerscoordinatethesearchforawildanimalinaresidentialareainTeltow,Germany,ThursdayJuly20

WSS

Protect nursing home residents from future pandemics

'Stay indoors': Escaped wild animal on the loose in Berlin prompts urgent citywide search

New research sheds light on how often breast cancer is overdiagnosed

Unmasking the 'centricity' illusion in clinical trials

Why some fertility treatments produce more boy babies

Why Congress must ban federal programs from using QALYs

explore

hotspot

leisure time

As demand for Covid shots wanes, Moderna seeks its next success

The world needs the new pandemic treaty

Medicare proposal to cover medical devices draws a mixed reaction

Wildfires rage amid heat wave in Greece, prompting evacuations and call for European support

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Pharma’s losing bet in New Jersey

Wildfire smoke exposes gaps in outdoor worker protections

Lawsuit challenges CMS nursing home minimum staffing rule

Psychedelics group wrestles with new pharma identity

Duchenne drug from Nippon Shinyaku fails in rare confirmatory trial

focus

Lawsuit challenges CMS nursing home minimum staffing rule

Beyond aggravation: Constipation is an American epidemic

Decentralized clinical trials need collaboration to achieve wider use

Ozempic cut risk of death in diabetes patients with chronic kidney disease

New research sheds light on how often breast cancer is overdiagnosed

Asahi Kasei to buy Calliditas, picking up kidney disease drug

hotspot

hotspot

knowledge

explore